News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Paper At Center Of Fabricated Data Scandal Is Retracted



12/9/2013 8:28:10 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline (NYSE: GSK) says the Nature Medicine journal has retracted an article that contained misleading data tied to the drug maker’s research program in China. GSK recommended withdrawing the article, published in 2010, after concluding an investigation in June that found some data had been misrepresented, London-based Glaxo said in a statement Friday. Five of the named authors, including the head of its Chinese research and development, resigned or were fired following the probe, it said.

Help employers find you! Check out all the jobs and post your resume.

Read at WRAL.com
Read at Pharmalot


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES